Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Cytek Biosciences, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Gifted 2,290,000 shares
@ $0 |
|
| 09/26/2023 |
4
| Jeanmonod Patrik (CFO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 3,000 shares
@ $6.38, valued at
$19.1k
|
|
| 08/21/2023 |
4
| Jeanmonod Patrik (CFO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 683 shares
@ $8.46, valued at
$5.8k
Paid exercise price by delivering 1,434 shares
@ $8.46, valued at
$12.1k
Exercised 1,752 restricted stock units
@ $0
Exercised 3,681 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,245 shares
@ $8.46, valued at
$19k
Paid exercise price by delivering 3,965 shares
@ $8.46, valued at
$33.5k
Exercised 6,758 restricted stock units
@ $0
Exercised 11,781 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Williams Paul Christopher (COO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 359 shares
@ $8.46, valued at
$3k
Exercised 920 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Barnett Valerie (General Counsel) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 786 shares
@ $8.46, valued at
$6.6k
Paid exercise price by delivering 1,434 shares
@ $8.46, valued at
$12.1k
Exercised 2,016 restricted stock units
@ $0
Exercised 3,681 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Poirson Allen (SVP Bus. and Corp. Dev.) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 308 shares
@ $8.46, valued at
$2.6k
Paid exercise price by delivering 975 shares
@ $8.46, valued at
$8.2k
Exercised 790 restricted stock units
@ $0
Exercised 2,503 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Garland Jonathan Todd (Chief Commercial Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 760 shares
@ $8.46, valued at
$6.4k
Paid exercise price by delivering 1,076 shares
@ $8.46, valued at
$9.1k
Exercised 1,951 restricted stock units
@ $0
Exercised 2,761 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $8.46, valued at
$6.5k
Paid exercise price by delivering 2,868 shares
@ $8.46, valued at
$24.3k
Sold 20,000 shares
@ $8.07, valued at
$161.4k
Exercised 1,981 restricted stock units
@ $0
Exercised 7,363 restricted stock units
@ $0 |
|
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| NEFF DEBORAH J (Director) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 30,242 options to buy
@ $8.38, valued at
$253.4k
|
|
| 06/16/2023 |
4
| Imper Vera (Director) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 30,242 options to buy
@ $8.38, valued at
$253.4k
|
|
| 06/16/2023 |
4
| HARDISON DON M (Director) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 30,242 options to buy
@ $8.38, valued at
$253.4k
|
|
| 06/16/2023 |
4
| Dion Gisele (Director) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 30,242 options to buy
@ $8.38, valued at
$253.4k
|
|
| 06/16/2023 |
4
| Ball Jack (Director) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 30,242 options to buy
@ $8.38, valued at
$253.4k
|
|
| 06/07/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $8.23, valued at
$164.6k
|
|
| 05/25/2023 |
4
| Jeanmonod Patrik (CFO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 3,000 shares
@ $7.76, valued at
$23.3k
|
|
| 05/19/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $6.69, valued at
$5.2k
Paid exercise price by delivering 1,912 shares
@ $6.69, valued at
$12.8k
Sold 20,000 shares
@ $7.19, valued at
$143.8k
Exercised 1,981 restricted stock units
@ $0
Exercised 4,908 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Barnett Valerie (General Counsel) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 786 shares
@ $6.69, valued at
$5.3k
Paid exercise price by delivering 956 shares
@ $6.69, valued at
$6.4k
Exercised 2,016 restricted stock units
@ $0
Exercised 2,454 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Williams Paul Christopher (COO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 239 shares
@ $6.69, valued at
$1.6k
Exercised 613 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Jeanmonod Patrik (CFO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 683 shares
@ $6.69, valued at
$4.6k
Paid exercise price by delivering 956 shares
@ $6.69, valued at
$6.4k
Exercised 1,752 restricted stock units
@ $0
Exercised 2,454 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,633 shares
@ $6.69, valued at
$17.6k
Paid exercise price by delivering 2,951 shares
@ $6.69, valued at
$19.7k
Exercised 6,758 restricted stock units
@ $0
Exercised 7,854 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Garland Jonathan Todd (Chief Commercial Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,040 shares
@ $6.69, valued at
$20.3k
Paid exercise price by delivering 717 shares
@ $6.69, valued at
$4.8k
Exercised 7,804 restricted stock units
@ $0
Exercised 1,840 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Poirson Allen (SVP Bus. and Corp. Dev.) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 308 shares
@ $6.69, valued at
$2.1k
Paid exercise price by delivering 651 shares
@ $6.69, valued at
$4.4k
Exercised 790 restricted stock units
@ $0
Exercised 1,669 restricted stock units
@ $0 |
|
| 05/10/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $11.55, valued at
$231k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2023 |
4
| Jeanmonod Patrik (CFO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 3,000 shares
@ $8.33, valued at
$25k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 178,062 options to buy
@ $10.61, valued at
$1.9M
Granted 117,813 restricted stock units
@ $0 |
|
|
|
|